"Graft Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
| Descriptor ID |
D006085
|
| MeSH Number(s) |
G12.875.545.340
|
| Concept/Terms |
Graft Survival- Graft Survival
- Graft Survivals
- Survival, Graft
- Survivals, Graft
|
Below are MeSH descriptors whose meaning is more general than "Graft Survival".
Below are MeSH descriptors whose meaning is more specific than "Graft Survival".
This graph shows the total number of publications written about "Graft Survival" by people in this website by year, and whether "Graft Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 3 | 3 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 4 | 7 | 11 |
| 2009 | 1 | 6 | 7 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 0 | 4 | 4 |
| 2016 | 1 | 3 | 4 |
| 2017 | 2 | 3 | 5 |
| 2018 | 0 | 5 | 5 |
| 2019 | 1 | 4 | 5 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft Survival" by people in Profiles.
-
Meniscal Allograft Transplantation: Indications, Techniques, Outcomes. Arthroscopy. 2020 04; 36(4):938-939.
-
Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysis. Transplantation. 2019 11; 103(11):2287-2303.
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
-
Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. Dig Liver Dis. 2020 01; 52(1):98-101.
-
Clinical Outcomes of Revision Osteochondral Allograft Transplantation. Arthroscopy. 2019 09; 35(9):2636-2645.
-
Analysis of Defect Size and Ratio to Condylar Size With Respect to Outcomes After Isolated Osteochondral Allograft Transplantation. Am J Sports Med. 2019 06; 47(7):1601-1612.
-
Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States. Ann Thorac Surg. 2019 04; 107(4):1046-1052.
-
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology. 2018 10; 68(4):1298-1307.
-
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int. 2018 07; 94(1):159-169.
-
No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant. Clin Transplant. 2018 05; 32(5):e13246.